Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer
Conditions: Merkel Cell Carcinoma; Small Cell Lung Cancer Interventions: Biological: XmAb18087; Drug: XmAb18087 ± Pembrolizumab Sponsors: Xencor, Inc.; ICON plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials